225 related articles for article (PubMed ID: 15933475)
21. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
22. Endocrine tumors of the gastrointestinal tract.
Haller DG
Curr Opin Oncol; 1994 Jan; 6(1):72-6. PubMed ID: 8204694
[TBL] [Abstract][Full Text] [Related]
23. The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas GA; Besser GM; Grossman AB
Endocr Rev; 2004 Jun; 25(3):458-511. PubMed ID: 15180952
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)].
Kos-Kudła B; Bolanowski M; Handkiewicz-Junak D; Jarzab B; Królicki L; Krzakowski M; Kunikowska J; Nasierowska-Guttmejer A; Nowak A; Rydzewska G; Starzyńska T; Szawłowski A;
Endokrynol Pol; 2008; 59(1):41-56. PubMed ID: 18335400
[TBL] [Abstract][Full Text] [Related]
25. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system].
Hörsch D; Sayeg Y; Bonnet R; Kaemmerer D; Presselt N; Baum RP
Pneumologie; 2012 Jan; 66(1):44-8. PubMed ID: 22250054
[TBL] [Abstract][Full Text] [Related]
26. [Neuroendocrine tumors of gastrointestinal tract: the paradigm that lasts].
Bjelović MM; Babić TD
Acta Chir Iugosl; 2013; 60(1):39-45. PubMed ID: 24669561
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
28. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
Scherübl H; Bäder M; Fett U; Hamm B; Schmidt-Gayk H; Koppenhagen K; Dop FJ; Riecken EO; Wiedenmann B
Gastroenterology; 1993 Dec; 105(6):1705-9. PubMed ID: 7902821
[TBL] [Abstract][Full Text] [Related]
30. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
31. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.
Castaño JP; Sundin A; Maecke HR; Villabona C; Vazquez-Albertino R; Navarro E; Oberg K
Cancer Metastasis Rev; 2014 Mar; 33(1):353-9. PubMed ID: 24390486
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis CG; Caplin ME
Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.
Oberg K
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):109-12. PubMed ID: 22584714
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract-Comparison of the Risk Factors and Non-Surgical Treatment Efficacy.
Lorenz A; Lenkiewicz S; Kozłowski M; Kwiatkowski S; Cymbaluk-Płoska A
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047829
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
Stevenson R; Libutti SK; Saif MW
JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.
Turaga KK; Kvols LK
CA Cancer J Clin; 2011; 61(2):113-32. PubMed ID: 21388967
[TBL] [Abstract][Full Text] [Related]
38. [Chromogranin A and neuroendocrine tumors].
Díaz Pérez JÁ; Currás Freixes M
Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
[TBL] [Abstract][Full Text] [Related]
39. [Neuroendocrine tumors of the gastrointestinal tract--diagnosis and therapy].
Scherübl H; Faiss S; Zeitz M
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S81-3. PubMed ID: 12817330
[No Abstract] [Full Text] [Related]
40. Somatostatin receptor imaging with (111)In-pentetreotide in gastro-intestinal tract and lung neuroendocrine tumors-Impact on targeted treatment.
Gerasimou G; Moralidis E; Gotzamani-Psarrakou A
Hell J Nucl Med; 2010; 13(2):158-62. PubMed ID: 20808990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
